MEGAN COLLIER: Open Payments
NPI 1851815385 · RAPID CITY, SD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$350 in 13 payments from 12 companies in 2025. Trend: 2023 $54 · 2024 $403 · 2025 $350
Food & beverage: $350
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 1 | $144 |
| Novartis Pharmaceuticals Corporation | 2 | $40 |
| Radius Health, Inc. | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| Astellas Pharma US Inc | 1 | $17 |
| Novo Nordisk Inc | 1 | $16 |
| Medtronic, Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $15 |
| Amgen Inc. | 1 | $15 |
Products named: REZDIFFRA, LEQVIO, Tymlos, JARDIANCE, FARXIGA, Veozah, Ozempic, MINIMED 780G.
Industry payments across SD — which companies pay providers there.
